Vir Biotechnology Inc
Biotechnology
Healthcare
VIR
137 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.32
52 week high
12.48
high
5.33
52 week low
0.00
low
5.13
growth
-33.38 %
previous Close
5.27
P/E ratio
market cap
748 M
div yield
0
usd
Mar 2025
qoq
revenue
1.79 M
-85.50 %
net incoming
-120.97 M
-15.66 %
eps
0.00 %
-15.79 %
eps surprise
-4.35 %
net profit margin
-6742.75 %
-5897.00 %
operating incoming
-139.55 M
-19.12 %
net change in cash
49.30 M
-9.32 %
cash on hand
274 M
22.71 %
cost of revenue
0.00 %
top top